6436-90-4
6436-90-4
Chemical Structure
N-Benzylglycine ethyl ester
- CAS No.: 6436-90-4
- Formula:C11H15NO2
- Molecular Weight:193.25
IUPAC Name: ethyl benzylglycinate
InChIKey: ULOLIZHBYWAICY-UHFFFAOYSA-N
SMILES: O=C(OCC)CNCC1=CC=CC=C1
Biological Activity: N-Benzylglycine ethyl ester is an N-substituted glycine derivative. N-Benzylglycine ethyl ester is bound to PDB code: 1B41. N-Benzylglycine ethyl ester can be used in Alzheimer's disease research[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
N-Benzylglycine ethyl ester | 98.61% | N-Benzylglycine ethyl ester is an N-substituted glycine derivative. N-Benzylglycine ethyl ester is bound to PDB code: 1B41. N-Benzylglycine ethyl ester can be used in Alzheimer's disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Manickavelu T, et al. Computational investigation, effects of polar and non-polar solvents on optimized structure with topological parameters (ELF, LOL, AIM, and RDG) of three glycine derivative compounds. Structural Chemistry, 2022, 33(4): 1295-1319.
- [2]. Williams JT, et al. Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials. J Med Chem. 2024 Feb 22;67(4):2337-2348. [Content Brief]
Keywords
